期刊文献+

QT间期延长综合征相关药物的合理应用及防治概述 被引量:16

Progress of Reasonable Application and Control in Long QT Syndrome Associated with Drugs
原文传递
导出
摘要 笔者从QT间期延长综合征(long Q-T syndrome,LQTS)的临床特征、机制与影响因素、药物相关性QT间期延长综合征及临床对其防治的国内外研究进展作一综述,提出临床药师需要关注易致QT间期延长的药物使用,预防临床发生药物致急性心律失常事件等,以促进临床合理用药、提高药物的安全性。 This article has made an review including definition of drug-related long QT interval,clinical features,mechanisms and influencing factors,prevention and treatment of drug-related QT long syndrome,and its clinical research progresses. It is proposed that clinical pharmacists need to focus more attention on QT prolongation drugs. It can prevent acute arrhythmic events,and promote rationality and safety of drug.
出处 《中国药学杂志》 CAS CSCD 北大核心 2015年第10期829-833,共5页 Chinese Pharmaceutical Journal
关键词 QT间期延长综合征 尖端扭转型室性心动过速 药物相互作用 long QT syndrome torsade de pointes drug interaction
  • 相关文献

参考文献9

二级参考文献94

  • 1顾瑞金.药物变态反应[M].北京:科学出版社,2000.72-74.
  • 2Shah,RR.Drugs,QT interval prolongation and ICH E14:the need to get it right[J].Drug Safety,2005; 28:115-2510ICH Harmonised Tripartite Guideline:The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs[S].E14,Step 4,12 May 2005,Page 8,Section 3.1
  • 3ICH Harmonised Tripartite Guideline:The clinica levaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs[S].E14,Step 4,12 May 2005,Page 9,Section 3.1.2
  • 4Roden DM.Drug-induced prolongation of the QT interval[J].N.Engl J Med.2005; 350:1013-22
  • 5International Conference on Harmonization.E14:the clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs (step 4)[EB/OL].http://www.ich.org/cache/compo/276-254-1.html.2005-7-15
  • 6International Conference on Harmonization.S7B:the nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals[EB/OL].http://www.ich.org/cache/compo/276-254-1.html
  • 7ICH Harmonized Tripartite Guideline:The non-clinical evaluation of the potential for delayed ventricular polarization (QT interval prolongation) by human pharmaceuticals[S].S7B,Step 4,12 May 2005,Page 2,Section 2.1
  • 8ICH Harmonized Tripartite Guideline:The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs[S].E14,Step 4,12 May 2005,Page 3,section 2.2
  • 9ICH Harmonized Tripartite Guideline:The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs[S].E14,Step 4,12 May 2005,Page 4,Section 2.2.1
  • 10ICH Harmonised Tripartite Guideline:The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs[S].E14,Step 4,12 May 2005,Page 3-4,Section 2.2.1

共引文献67

同被引文献113

引证文献16

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部